Yahoo
OTC Markets OTCQB - Delayed Quote USD

Northwest Biotherapeutics, Inc. (NWBO)

0.1700 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,173
--
--
--
--
Operating Expense
52,502
61,292
67,890
57,440
68,864
Operating Income
-50,329
-59,914
-66,508
-55,508
-67,181
Net Non Operating Interest Income Expense
-9,422
-8,695
-7,767
-5,241
-6,068
Other Income Expense
21,483
7,910
-9,503
-1,850
-31,783
Pretax Income
-38,268
-60,699
-83,778
-62,599
-105,032
Tax Provision
--
-537
0
--
--
Net Income Common Stockholders
-38,883
-61,477
-85,192
-64,373
-105,032
Diluted NI Available to Com Stockholders
-38,883
-61,477
-85,192
-64,373
-105,032
Basic EPS
-0.02
-0.04
-0.07
-0.06
-0.10
Diluted EPS
-0.02
-0.04
-0.07
-0.06
-0.10
Basic Average Shares
1,564,031
1,456,663
1,242,237
1,119,191
1,015,852
Diluted Average Shares
1,564,031
1,456,663
1,242,237
1,119,191
1,015,852
Total Operating Income as Reported
-50,329
-59,914
-66,508
-55,508
-67,181
Total Expenses
52,502
61,292
67,890
57,440
68,864
Net Income from Continuing & Discontinued Operation
-37,731
-60,162
-83,778
-62,599
-105,032
Normalized Income
-63,828
-73,045
-75,094
-60,827
-73,216
Interest Expense
9,422
8,695
7,767
5,241
6,068
Net Interest Income
-9,422
-8,695
-7,767
-5,241
-6,068
EBIT
-28,846
-52,004
-76,011
-57,358
-98,964
EBITDA
-25,825
-49,667
-73,967
-55,625
-97,464
Reconciled Depreciation
3,021
2,337
2,044
1,733
1,500
Net Income from Continuing Operation Net Minority Interest
-37,731
-60,162
-83,778
-62,599
-105,032
Total Unusual Items Excluding Goodwill
26,097
13,000
-8,684
-1,772
-31,816
Total Unusual Items
26,097
13,000
-8,684
-1,772
-31,816
Normalized EBITDA
-51,922
-62,667
-65,283
-53,853
-65,648
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
117
0
0
0
12/31/2022 - 12/14/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: